Abstract:(1) Background: Niemann-Pick type C1 (NP-C1) is a lysosomal storage disorder that results in the defective trafficking of cholesterol and other cellular lipids in the endosomal-lysosomal pathway. This rare autosomal recessive disorder presents in three forms based on the age of onset. The adult form presents in patients greater than 15 years of age but is rarely seen after the age of 30. Common symptoms of the late adult-onset category of NP-C1 include progressive cognitive impairment and ataxia, with psychiatric and movement disorders presenting less frequently than in other forms of NP-C1. Dystonic movement disorders present most frequently, along with chorea, myoclonus, and parkinsonism. Herein, we present a rare case of NP-C1, diagnosed at age 35 with an initial symptom of supranuclear palsy. The goal of the presented case is to highlight the importance of the neurological examination and an inclusive differential diagnosis in patients with new-onset supranuclear palsy. (2) Methods: A single case report. (3) Results: A 46-year-old male with a past medical history of NP-C1 was admitted to the hospital for respiratory distress. He was noted to have a supranuclear gaze palsy with partially preserved voluntary saccades to the right. His mother revealed that he first had difficulty moving his eyes at the age of 34. After multiple consultations and genetic testing one year later, he was diagnosed with NP-C1. (4) Conclusions: Because NP-C1 affects many regions of the brain responsible for eye movements, neurological eye assessments can be a useful tool in diagnoses. Furthermore, eye movement abnormalities may be the initial presenting symptom of NP-C1, predisposing patients to misdiagnosis with progressive supranuclear palsy and other conditions that may mimic early-stage NP-C1. Definitive diagnosis is achieved through genetic testing. Filipin staining test was the gold standard in the past. The NP-C Suspicion Index was developed to assist in diagnoses, but its efficacy is unclear with late adult-onset NP-C1. Although no cure exists, early identification can facilitate an improved symptom management course for patients. Miglustat, a glucosylceramide synthase (GCS) inhibitor, is the approved therapy in Europe specific to NP-C1 for slowing and preventing the neurological manifestations of NP-C1. Delays between symptom onset and treatment initiation are likely to result in poorer outcomes and a progression of neurological symptoms. High doses may present tolerance concerns, especially in cases of delayed treatment and advanced neurological deficit.

Supranuclear Palsy as an Initial Presentation of the Adult-Onset Niemann-Pick Type C

Niemann-Pick Disease Type C: Analysis of 7 Patients

Genetic and laboratory diagnostic approach in Niemann Pick disease type C

Clinical analysis of 4 case of Niemann-Pick disease type C

Laboratory diagnosis of the Niemann-Pick type C disease: an inherited neurodegenerative disorder of cholesterol metabolism

Neurodegeneration in Niemann-Pick type C disease mice

Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management

Clinical, ocular motor, and imaging profile of Niemann-Pick type C heterozygosity

Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann–Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report

Diagnosis of Niemann-Pick Disease Type C with 7-Ketocholesterol Screening Followed by NPC1/NPC2 Gene Mutation Confirmation in Chinese Patients

Characterization of central manifestations in patients with Niemann-Pick disease type C

Adult-onset neuronal ceroid lipofuscinosis misdiagnosed as autoimmune encephalitis and normal-pressure hydrocephalus: A 10-year case report and case-based review

Alterations in Proteostasis Mechanisms in Niemann–Pick Type C Disease

Differential Interferon Signaling Regulation and Oxidative Stress Responses in the Cerebral Cortex and Cerebellum Could Account for the Spatiotemporal Pattern of Neurodegeneration in Niemann–Pick Disease Type C

Genetic and phenotypic variability in adult patients with Niemann Pick type C from Serbia: single-center experience

Clinical, biochemical, and genotype‐phenotype correlations of 118 patients with Niemann‐Pick disease Types A/B

Genetic and Clinical Characterization of Niemann-Pick Disease Type C with Homozygous NPC1 gene mutation: Insights from whole exome sequencing and advanced neuroimaging of two familial cases

Swallowing characterization of adult-onset Niemann-Pick, type C1 patients

Importance of the biochemical investigations for the functional characterization of a NPC1 variant identified by exome sequencing

Expanding the Clinical Spectrum of Adult-Onset Neuronal Intranuclear Inclusion Disease

Neuronal intranuclear inclusion disease mimicking progressive supranuclear palsy